1. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010; 28(41): 6653-7. doi.10.1016/j.vaccine.2010.08.037 PMid:20723630

2. Lemon SM, Ott JJ, Van Damme P, Shouval D. Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J Hepatol. 2018;68(1):167-84. doi.10.1016/j.jhep.2017.08.034 PMid:28887164

3. Migueres M, Lhomme S, Izopet J. Hepatitis A: epidemiology, high-risk groups, prevention and research on antiviral treatment. Viruses. 2021; 13(10): 1900. doi.10.3390/v13101900 PMid:34696330 PMCid:PMC8540458

4. Gluud LL, Gluud C. Meta-analyses on viral hepatitis. Infect Dis Clin North Am. 2009;23(2):315-30. doi.10.1016/j.idc.2009.01.005 PMid:19393912

5. Chi V, Cleary S, Bocchini Jr JA. In pursuit of control and elimination: update on hepatitis A and B epidemiology and prevention strategies. Curr Opin Pediatr. 2018; 30(5): 689-97. doi.10.1097/MOP.0000000000000672 PMid:30188873

6. Jacobsen KH. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb Perspect Med. 2018;8(10):a031716. doi.10.1101/cshperspect.a031716 PMid:29500305 PMCid:PMC6169986

7. Antaki NA, Kebbewar M. Hepatitis A seroprevalence rate in Syria. 2000. (Note: This entry lacks standard journal/publication details and cannot be fully formatted). doi.10.1177/004947550003000215 PMid:10842558

8. Obiesie IV, Dadah AJ, Nmadu AG. Prevalence of Hepatitis A among internally displaced persons in Municipal Area Council, Abuja-Nigeria. Sci World J. 2021; 16(3):245-8.

9. McKnight KL, Lemon SM. Hepatitis A virus genome organization and replication strategy. Cold Spring Harb Perspect Med. 2018; 8(12): a033480. doi.10.1101/cshperspect.a033480 PMid:29610147 PMCid:PMC6280712

10. World Health Organization. WHO Immunological Basis for Immunization Series, Module 18: Hepatitis A Update. WHO, Geneva, Switzerland. 2019.

11. Van Damme P, Pintó RM, Feng Z, Cui F, Gentile A, Shouval D. Hepatitis A virus infection. Nat Rev Dis Primers. 2023; 9(1): 51. doi.10.1038/s41572-023-00461-2 PMid:37770459

12. Michaelis K, Poethko-Müller C, Kuhnert R, Stark K, Faber M. Hepatitis A virus infections, immunisations and demographic determinants in children and adolescents, Germany. Sci Rep. 2018; 8(1):16696. doi.10.1038/s41598-018-34927-1 PMid:30420608 PMCid:PMC6232152

13. Alijanzadeh Maliji B, Babayeemehr A, Rohani K, Mehrabani S, Aghajanpour F. Role of the World Health Organization in Management of Gastrointestinal Diseases Caused by Contaminated Water in Children in the Middle East: A Review Article. J Pediatr Rev. 2023; 11(1): 59-66. doi.10.32598/jpr.11.1.285.2

14. Saha SK, Saha S, Shakur S, Hanif M, Habib MA, Datta SK, et al. Community-based cross-sectional seroprevalence study of hepatitis A in Bangladesh. World J Gastroenterol. 2009; 15(39): 4932. doi.10.3748/wjg.15.4932 PMid:19842225 PMCid:PMC2764972

15. López-Gatell H, García-García L, Echániz-Avilés G, Cruz-Hervert P, Olamendi-Portugal M, Castañeda-Desales D, et al. Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis. Vaccine. 2018; 36(52): 8094-9. doi.10.1016/j.vaccine.2018.10.037 PMid:30337174

16. Behzadi MA, Leyva-Grado VH, Namayandeh M, Ziyaeyan A, Feyznezhad R, Dorzaban H, et al. Seroprevalence of viral hepatitis A, B, C, D and E viruses in the Hormozgan province southern Iran. BMC Infect Dis. 2019;19:1-12. doi.10.1186/s12879-019-4661-4 PMid:31795979 PMCid:PMC6889522

17. Quaglio G, Ramadani N, Pattaro C, Cami A, Dentico P, Volpe A, et al. Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy. J Med Virol. 2008;80(5):833-40. doi.10.1002/jmv.21141 PMid:18360897

18. Altınkaynak S, Selimoğlu MA, Ertekin V, Kılıçaslan B. Epidemiological factors affecting hepatitis a seroprevalence in childhood in a developing country. Eurasian J Med. 2008; 40(1): 25.

19. Farajzadegan Z, Hoseini SG, Kelishadi R, Jamshidi F, Nokhodian Z, Noori R, et al. Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran. J Res Med Sci. 2014; 19(Suppl 1):S56.

20. Merat S, Rezvan H, Nouraei M, Abou Alghasemi H, Jamali R, Amini KS, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. 2010.

21. Fares A. Seasonality of hepatitis: a review update. J Family Med Prim Care. 2015;4(1):96-100. doi.10.4103/2249-4863.152263 PMid:25810997 PMCid:PMC4367015